Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata City, Japan.
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata City, Japan.
Eur J Surg Oncol. 2019 Aug;45(8):1446-1452. doi: 10.1016/j.ejso.2019.03.038. Epub 2019 Mar 30.
This study aimed to investigate the incidence and distribution of regional lymph node metastasis according to tumor location, and to clarify whether tumor location could determine the extent of regional lymphadenectomy in patients with pathological T2 (pT2) gallbladder carcinoma.
In total, 81 patients with pT2 gallbladder carcinoma (25 with pT2a tumors and 56 with pT2b tumors) who underwent radical resection were enrolled. Tumor location was determined histologically in each gallbladder specimen.
Survival after resection was significantly worse in patients with pT2b tumors than those with pT2a tumors (5-year survival, 72% vs. 96%; p = 0.027). Tumor location was an independent prognostic factor on multivariate analysis (hazard ratio, 14.162; p = 0.018). The incidence of regional lymph node metastasis was significantly higher in patients with pT2b tumors than in those with pT2a tumors (46% vs. 20%; p = 0.028). However, the number of positive nodes was similar between the two groups (median, 2 vs. 2; p = 0.910). For node-positive patients with pT2b tumors, metastasis was found in every regional node group (12%-63%), whereas even for node-positive patients with pT2a tumors, metastasis was observed in regional node groups outside the hepatoduodenal ligament.
Tumor location in patients with pT2 gallbladder carcinoma can predict the presence or absence of regional lymph node metastasis but not the number and anatomical distribution of positive regional lymph nodes. The extent of regional lymphadenectomy should not be changed even in patients with pT2a tumors, provided that they are fit enough for surgery.
本研究旨在根据肿瘤位置调查局部淋巴结转移的发生率和分布,并阐明肿瘤位置是否能确定病理 T2(pT2)胆囊癌患者的区域淋巴结清扫范围。
共纳入 81 例接受根治性切除术的 pT2 胆囊癌患者(pT2a 肿瘤 25 例,pT2b 肿瘤 56 例)。每个胆囊标本均通过组织学确定肿瘤位置。
pT2b 肿瘤患者的切除后生存明显差于 pT2a 肿瘤患者(5 年生存率,72%比 96%;p=0.027)。肿瘤位置是多因素分析的独立预后因素(危险比,14.162;p=0.018)。pT2b 肿瘤患者的局部淋巴结转移发生率明显高于 pT2a 肿瘤患者(46%比 20%;p=0.028)。然而,两组阳性淋巴结的数量相似(中位数,2 比 2;p=0.910)。对于 pT2b 肿瘤的阳性淋巴结患者,转移发生在每个区域淋巴结组(12%-63%),而即使对于 pT2a 肿瘤的阳性淋巴结患者,也观察到肝十二指肠韧带外的区域淋巴结组存在转移。
pT2 胆囊癌患者的肿瘤位置可预测局部淋巴结转移的存在与否,但不能预测阳性区域淋巴结的数量和解剖分布。只要患者适合手术,即使是 pT2a 肿瘤患者,也不应改变区域淋巴结清扫的范围。